Inactive Instrument

Highlights BioMerieux SA Xetra

Equities

BIOMÉRIEUX : Berenberg raises its target	26/04	CF
BIOMÉRIEUX : Stifel raises target price	10/04	CF
BIOMÉRIEUX : Oddo BHF raises its target price	10/04	CF
BIOMÉRIEUX : Invest Securities raises its target	10/04	CF
BIOMERIEUX : A strong start to 2024	09/04
BioMérieux: hailed for its business review and targets	09/04	CF
BioMérieux: targets set for 2024-28	09/04	CF
BioMérieux: growth of over 6% in Q1	09/04	CF
BioMérieux: food safety initiative	05/04	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	14/03
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
BioMérieux: RNPG down 21% in 2023	14/03	CF
BioMérieux Buys Remaining 84% Stake in Canada's Lumed	08/01	MT
BioMérieux: full acquisition of Lumed	08/01	CF
BioMérieux S.A. acquired remaining 84% stake in Luméd inc.	05/01	CI
BIOMÉRIEUX : Invest Securities remains Buy after sales figures	27/23/27	CF
BioMérieux: confirms targets for fiscal 2023	26/23/26	CF
BioMerieux Partners with White Labs to Develop GENE-Up® BrewPRO? Yeast Slurry	24/23/24	CI
Oxford Nanopore gets bioMerieux backing as announces clinical foray	19/23/19	AN
BioMérieux Invests GBP70 Million in Oxford Nanopore Technologies	19/23/19	MT

No results for this search

BIOMERIEUX : A strong start to 2024

April 09, 2024 at 08:08 pm IST